Cite
Doggrell SA, Christensen AM. Does the p38 MAP kinase inhibitor pamapimod have potential for the treatment of rheumatoid arthritis?. Expert Opin Pharmacother. 2010;11(14):2437-42doi: 10.1517/14656566.2010.507631.
Doggrell, S. A., & Christensen, A. M. (2010). Does the p38 MAP kinase inhibitor pamapimod have potential for the treatment of rheumatoid arthritis?. Expert opinion on pharmacotherapy, 11(14), 2437-42. https://doi.org/10.1517/14656566.2010.507631
Doggrell, Sheila A, and Christensen, Anne-Marie. "Does the p38 MAP kinase inhibitor pamapimod have potential for the treatment of rheumatoid arthritis?." Expert opinion on pharmacotherapy vol. 11,14 (2010): 2437-42. doi: https://doi.org/10.1517/14656566.2010.507631
Doggrell SA, Christensen AM. Does the p38 MAP kinase inhibitor pamapimod have potential for the treatment of rheumatoid arthritis?. Expert Opin Pharmacother. 2010 Oct;11(14):2437-42. doi: 10.1517/14656566.2010.507631. PMID: 20666701.
Copy
Download .nbib